India, Nov. 12 -- Pharma major Lupin Ltd announced on Wednesday that its wholly-owned subsidiary, Lupin Manufacturing Solutions (LMS), has commissioned a dedicated oncology block at its Vizag manufacturing facility in Andhra Pradesh.
The newly inaugurated high-containment unit enhances LMS's end-to-end contract development and manufacturing (CDMO) capabilities for high-potent active pharmaceutical ingredients (HPAPIs).
According to the company, the facility will cater to clients across the oncology drug development lifecycle—from preclinical research to commercial-scale production—to meet the rising global demand for oncology drug development and manufacturing services.
Published by HT Digital Content Services with permission...